The Effect of Hypertonic Resuscitation for Blunt Trauma

高渗复苏治疗钝挫伤的效果

• 批准号: 6746971
• 负责人: EILEEN M BULGER
• 金额: $ 43.62万
• 依托单位: UNIVERSITY OF WASHINGTON
• 依托单位国家: 美国
• 财政年份: 2003
• 资助国家: 美国
• 起止时间: 2003-04-01 至 2007-03-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6746971
• 关键词: adult respiratory distress syndrome; brain injury; cellular immunity; clinical research; clinical trials; dextrans; helper T lymphocyte; human subject; human therapy evaluation; hypovolemia; interleukin 10; interleukin 2; interleukin 4; leukocyte activation /transformation; monocyte; multiple organ failure; neuroprotectants; neutrophil; outcomes research; patient oriented research; resuscitation; saline; shock; trauma

DESCRIPTION (provided by applicant): Conventional resuscitation of hypovolemic shock following traumatic injury involves the rapid administration of large volumes of lactated ringers (LR) solution. Previous research suggests that initial resuscitation with a hypertonic solution will result in more rapid restoration of blood pressure, improved cerebral perfusion, and modulation of the systemic inflammatory response to ischemia/reperfusion injury. This proposal seeks to evaluate the clinical outcome and inflammatory cell function of patients in shock following blunt traumatic injury who are randomized to receive 7.5% hypertonic saline/6% dextran (HSD) followed by LR versus LR alone. We hypothesize that HSD resuscitation will inhibit the initial excessive systemic activation of the inflammatory response, which will translate into a reduction in the incidence of organ dysfunction induced by this response. Furthermore, we seek to evaluate the impact of HSD resuscitation on recovery following traumatic brain injury, as previous studies suggest that this subgroup has the greatest survival advantage from this intervention. The specific aims for this proposal include: Aim 1: To determine the impact of pre-hospital administration of hypertonic saline/dextran on the development of organ failure following blunt traumatic injury with hypovolemic shock. Aim 2: To determine the impact of prehospital administration of hypertonic saline/dextran on the neurologic outcome following brain injury" for patients in hypovolemic shock. Aim 3a: To determine the effect of prehospital administration of hypertonic saline/dextran on the activation of circulating neutrophils and monocytes. Aim 3b: To determine the effect of prehospital administration of hypertonic saline/dextran on the activation of T lymphocytes. This proposal builds upon previous research which has demonstrated the safety and practicality of this resuscitation strategy in the prehospital environment. A more detailed understanding of the immuno-inflammatory effects of hypertonicity for all patients and the long-term neurologic outcome for patients with brain injury is critical to determining the role of this resuscitation approach in these critically injured patients.

描述（由申请人提供）： 创伤后低血容量性休克的常规复苏包括快速 给予大体积的乳酸林格氏（LR）溶液。先前的研究表明，高渗溶液的初始复苏将导致更快的血压恢复，改善脑灌注，并调节对缺血/再灌注损伤的全身炎症反应。该提案旨在评估钝性创伤后休克患者的临床结局和炎症细胞功能，这些患者随机接受7.5%高渗盐水/6%右旋糖酐（HSD），随后接受LR与单独接受LR。我们假设HSD复苏将抑制炎症反应的初始过度全身激活，这将转化为由该反应诱导的器官功能障碍发生率的降低。此外，我们试图评估HSD复苏对创伤性脑损伤后恢复的影响，因为以前的研究表明，该亚组在这种干预中具有最大的生存优势。本提案的具体目的包括：目的1：确定院前给予高渗盐水/右旋糖酐对钝性创伤伴低血容量性休克后器官衰竭发展的影响。 目标二：确定院前给予高渗盐水/右旋糖酐对低血容量性休克患者脑损伤后神经功能结局的影响。目的3a：确定院前给予高渗盐水/右旋糖酐对循环中性粒细胞和单核细胞活化的影响。 目的3b：探讨院前应用高渗盐水/右旋糖酐对T淋巴细胞活化的影响。该建议建立在先前的研究基础上，这些研究已经证明了这种复苏策略在院前环境中的安全性和实用性。更详细地了解高渗对所有患者的免疫炎症影响以及脑损伤患者的长期神经学结局对于确定这种复苏方法在这些危重患者中的作用至关重要。